• 1. Distribution and ecological risk assessment of typical antibiotics in the surface waters of seven major rivers, China?
  Environ. Sci.: Processes Impacts, 2021,23, 1088-1100
• 2. Evolved polymerases facilitate selection of fully 2′-OMe-modified aptamers?
  Zhixia Liu,Tingjian Chen,Floyd E. Romesberg Chem. Sci., 2017,8, 8179-8182
• 3. Elusive 2-aminofuran Diels–Alder substrates for a straightforward synthesis of polysubstituted anilines?
  Ana G. Neo,Ana Bornadiego,Jesús Díaz,Stefano Marcaccini,Carlos F. Marcos Org. Biomol. Chem., 2013,11, 6546-6555
• 4. Excellent electrochemical performance of LiFe0.4Mn0.6PO4 microspheres produced using a double carbon coating process?
  Yong Ping Huang,Tao Tao,Zheng Chen,Wei Han,Ying Wu,Chunjiang Kuang,Shaoxiong Zhou,Ying Chen J. Mater. Chem. A, 2014,2, 18831-18837
• 5. Excited state potential energy surfaces and their interactions in FeIVO active sites
  Shaun D. Wong,Edward I. Solomon Dalton Trans., 2014,43, 17567-17577

Comprehensive Overview of 4-bromo-2-(3,5-dichlorophenoxy)benzaldehyde (CAS No. 1153550-29-8)

4-bromo-2-(3,5-dichlorophenoxy)benzaldehyde (CAS No. 1153550-29-8) is a specialized organic compound that has garnered significant attention in the fields of pharmaceutical research, agrochemical development, and material science. This compound, characterized by its unique brominated and dichlorophenoxy structure, serves as a versatile intermediate in the synthesis of more complex molecules. Its molecular formula, C₁₃H₇BrCl₂O₂, highlights its potential for diverse applications, particularly in the design of novel bioactive agents.

The compound's benzaldehyde core, modified with 4-bromo and 3,5-dichlorophenoxy substituents, imparts distinct electronic and steric properties. These features make it a valuable building block in medicinal chemistry, where researchers are increasingly exploring halogenated compounds for their enhanced binding affinity and metabolic stability. Recent studies have highlighted the role of 4-bromo-2-(3,5-dichlorophenoxy)benzaldehyde in the development of enzyme inhibitors and receptor modulators, aligning with the growing demand for targeted therapies in precision medicine.

In the context of green chemistry and sustainable synthesis, CAS 1153550-29-8 has emerged as a subject of interest due to its potential for eco-friendly derivatization. Researchers are investigating catalytic methods to functionalize this compound while minimizing waste and energy consumption. This aligns with global trends toward environmentally conscious chemical production, a topic frequently searched in academic and industrial forums.

The compound's spectroscopic properties (including distinctive NMR and IR signatures) and crystallographic data have been extensively documented, making it a reliable reference material for analytical laboratories. Its purity and stability under standard storage conditions further enhance its utility as a research chemical. Notably, the 3,5-dichlorophenoxy moiety contributes to its lipophilicity, a property highly relevant in drug design for optimizing membrane permeability.

From a commercial perspective, 4-bromo-2-(3,5-dichlorophenoxy)benzaldehyde is manufactured under strict quality control protocols to meet the requirements of pharmaceutical GMP applications. Its synthesis typically involves multi-step organic transformations, with careful optimization to maximize yield and minimize byproducts. The compound's safety profile has been evaluated for research use, though proper handling procedures are always recommended for laboratory personnel.

Emerging applications of this compound include its use in advanced material science, particularly in the development of organic semiconductors and liquid crystal displays. The electron-withdrawing nature of its substituents makes it an interesting candidate for molecular engineering of optoelectronic materials. This connects with current industry focus on flexible electronics and energy-efficient display technologies.

For researchers investigating structure-activity relationships, 1153550-29-8 provides a valuable template for studying the effects of halogen substitution patterns on biological activity. Computational chemistry studies utilizing this compound have contributed to better understanding of molecular docking interactions, particularly in protein binding sites that prefer halogen bonding partners.

The compound's stability under various pH conditions and its solubility profile in organic solvents make it particularly useful for high-throughput screening applications. Many pharmaceutical companies maintain this chemical in their screening libraries due to its privileged scaffold characteristics. Recent patent literature reveals derivatives of 4-bromo-2-(3,5-dichlorophenoxy)benzaldehyde appearing in claims for new therapeutic agents, particularly in antimicrobial and anti-inflammatory domains.

Analytical methods for 4-bromo-2-(3,5-dichlorophenoxy)benzaldehyde quantification have been developed using HPLC and GC techniques, with published protocols available for quality control purposes. The compound's UV absorption characteristics also make it suitable for photochemical studies, an area gaining traction in sustainable synthesis methodologies.

In regulatory aspects, CAS 1153550-29-8 is properly classified according to global chemical inventories (such as TSCA and EINECS), ensuring compliance for international trade and research collaboration. Proper documentation including safety data sheets is available from reputable suppliers, addressing another common search query among laboratory professionals.

Future research directions for this compound may explore its potential in click chemistry applications, given the reactivity of its aldehyde functionality. The combination of bromine and dichlorophenoxy groups offers multiple sites for further functionalization, making it a promising candidate for library synthesis in drug discovery programs.

• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)